Hypertranscription of rDNA Responsible for Nucleolar Remodelling is a Doorman for Acquiring Pluripotency

Abstract

Ribosome biogenesis occurs within the nucleolus, with the initial step being the transcription of ribosomal DNA (rDNA). Although rDNA transcription is limited in somatic cells, it is more active in stem cells. Nevertheless, the mechanisms involved in somatic cell reprogramming remain elusive. Both somatic and stem cell nucleoli exhibit a reticular structure. However, under the electron microscope, we identified an intermediate nucleolar state during reprogramming. This state underwent changes characterised by rDNA hypertranscription, resulting in an enlarged nucleolus, enhanced activity of nucleolus organiser regions (NORs), and a transition from the reticular nucleolar type to an intermediate state of reprogramming, whose three liquid phase boundaries are blurred. Our research revealed that Oct4 was directly targeted to the rDNA enhancer region, promoting its hypertranscription and nucleolar enlargement during reprogramming. Using rDNA transcriptional inhibitors, we proved that nucleolar remodelling and subsequent reprogramming are halted by inhibiting rDNA transcription. But why could rDNA transcriptional activity influence reprogramming? Our findings elucidate that the active nucleoli have the capability to release perinucleolar heterochromatin. By joint analysis of Assay for Transposase-Accessible Chromatin with high throughput sequencing (ATAC-seq) and RNA-seq, we have characterised the perinucleolar chromatin released by the nucleolus in a reprogramming intermediate state. The released chromatin mainly impacted mesenchymal-to-epithelial transition (MET)-related genes. MET is a stage of silencing of mesenchymal genes, accompanied by the activation of epithelial genes. Concurrently, the morphology of mouse embryonic fibroblast cells (MEFs) transitions from elongated spindle-shaped cells to short roundish forms, exhibiting a propensity to cluster together. MET was considered an early event in reprogramming; our findings suggested that nucleolar remodelling occurred before MET.

Keywords

chromatin accessibility / iPSC reprogramming / nucleoli / rDNA

References

[1] M. van Sluis, C. van Vuuren, H. Mangan, and B. McStay, “NORs on Human Acrocentric Chromosome p-Arms Are Active by Default and Can Associate With Nucleoli Independently of rDNA,” Proceedings of the National Academy of Sciences of the United States of America 117, no. 19 (2020): 10368-10377, https://doi.org/10.1073/pnas.2001812117.

[2] R. W. Yao, G. Xu, Y. Wang, et al., “Nascent Pre-rRNA Sorting via Phase Separation Drives the Assembly of Dense Fibrillar Components in the Human Nucleolus,” Molecular Cell 76, no. 5 (2019): 767-783.e11.

[3] B. Fu, H. Ma, and D. Liu, “Essential Roles of the Nucleolus During Early Embryonic Development: A Regulatory Hub for Chromatin Organization,” Open Biology 14, no. 5 (2024): 230358.

[4] N. Hamdane, V. Y. Stefanovsky, M. G. Tremblay, et al., “Conditional Inactivation of Upstream Binding Factor Reveals Its Epigenetic Functions and the Existence of a Somatic Nucleolar Precursor Body,” PLoS Genetics 10, no. 8 (2014): e1004505, https://doi.org/10.1371/journal.pgen.1004505.

[5] H. Fulka, J. Rychtarova, and P. Loi, “The Nucleolus-Like and Precursor Bodies of Mammalian Oocytes and Embryos and Their Possible Role in Post-Fertilization Centromere Remodelling,” Biochemical Society Transactions 48, no. 2 (2020): 581-593.

[6] H. Yu, Z. Sun, T. Tan, et al., “rRNA Biogenesis Regulates Mouse 2C-Like State by 3D Structure Reorganization of Peri-Nucleolar Heterochromatin,” Nature Communications 12, no. 1 (2021): 6365, https://doi.org/10.1038/s41467-021-26576-2.

[7] Z. Zheng, J. L. Jia, G. Bou, et al., “rRNA Genes Are Not Fully Activated in Mouse Somatic Cell Nuclear Transfer Embryos,” Journal of Biological Chemistry 287, no. 24 (2012): 19949-19960, https://doi.org/10.1074/jbc.M112.355099.

[8] C. Liao, N. Pang, Z. Liu, and L. Lei, “Transient Inhibition of rDNA Transcription in Donor Cells Improves Ribosome Biogenesis and Preimplantation Development of Embryos Derived From Somatic Cell Nuclear Transfer,” FASEB Journal 34, no. 6 (2020): 8283-8295, https://doi.org/10.1096/fj.202000025RR.

[9] D. H. Arabacı, G. Terzioğlu, B. Bayırbaşı, and T. T. Önder, “Going Up the Hill: Chromatin-Based Barriers to Epigenetic Reprogramming,” FEBS Journal 288, no. 16 (2021): 4798-4811, https://doi.org/10.1111/febs.15628.

[10] T. A. Potapova, J. R. Unruh, Z. Yu, et al., “Superresolution Microscopy Reveals Linkages Between Ribosomal DNA on Heterologous Chromosomes,” Journal of Cell Biology 218, no. 8 (2019): 2492-2513, https://doi.org/10.1083/jcb.201810166.

[11] Q. Zhao, Y. Wu, Z. Shan, et al., “Serum Starvation-Induced Cell Cycle Synchronization Stimulated Mouse rDNA Transcription Reactivation During Somatic Cell Reprogramming Into iPSCs,” Stem Cell Research & Therapy 7, no. 1 (2016): 112, https://doi.org/10.1186/s13287-016-0369-1.

[12] T. Tan, B. Gao, H. Yu, et al., “Dynamic Nucleolar Phase Separation Influenced by Non-Canonical Function of LIN28A Instructs Pluripotent Stem Cell Fate Decisions,” Nature Communications 15, no. 1 (2024): 1256, https://doi.org/10.1038/s41467-024-45451-4.

[13] T. Peng, Y. Hou, H. Meng, et al., “Mapping Nucleolus-Associated Chromatin Interactions Using Nucleolus Hi-C Reveals Pattern of Heterochromatin Interactions,” Nature Communications 14, no. 1 (2023): 350, https://doi.org/10.1038/s41467-023-36021-1.

[14] C. Ward, G. Volpe, P. Cauchy, et al., “Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-To-Epithelial Transition During Somatic Reprogramming,” Cell Reports 24, no. 6 (2018): 1496-1511.e8.

[15] S. Velychko, K. Adachi, K. P. Kim, et al., “Excluding Oct4 From Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs,” Cell Stem Cell 25, no. 6 (2019): 737-753.e4.

[16] Y. Sun, X. Hu, D. Qiu, Z. Zhang, and L. Lei, “rDNA Transcription in Developmental Diseases and Stem Cells,” Stem Cell Reviews and Reports 19, no. 4 (2023): 839-852, https://doi.org/10.1007/s12015-023-10504-6.

[17] S. Nair, M. Ameen, L. Sundaram, et al., “Transcription Factor Stoichiometry, Motif Affinity and Syntax Regulate Single-Cell Chromatin Dynamics During Fibroblast Reprogramming to Pluripotency,” (2023), bioRxiv.

[18] G. Quiroga-Artigas, D. de Jong, and C. E. Schnitzler, “GNL3 Is an Evolutionarily Conserved Stem Cell Gene Influencing Cell Proliferation, Animal Growth and Regeneration in the Hydrozoan Hydractinia,” Open Biology 12, no. 9 (2022): 220120, https://doi.org/10.1098/rsob.220120.

[19] J. Wang, D. J. McGrail, P. K. Bhupal, et al., “Nucleostemin Modulates Outcomes of Hepatocellular Carcinoma via a Tumor Adaptive Mechanism to Genomic Stress,” Molecular Cancer Research 18, no. 5 (2020): 723-734, https://doi.org/10.1158/1541-7786.MCR-19-0777.

[20] J. Bassler, P. Grandi, O. Gadal, et al., “Identification of a 60S Preribosomal Particle That Is Closely Linked to Nuclear Export,” Molecular Cell 8, no. 3 (2001): 517-529.

[21] R. Y. Tsai, “Nucleolar Modulation of TRF1: A Dynamic Way to Regulate Telomere and Cell Cycle by Nucleostemin and GNL3L,” Cell Cycle 8, no. 18 (2009): 2912-2916, https://doi.org/10.4161/cc.8.18.9543.

[22] R. Y. Tsai and R. D. McKay, “A Nucleolar Mechanism Controlling Cell Proliferation in Stem Cells and Cancer Cells,” Genes & Development 16, no. 23 (2002): 2991-3003, https://doi.org/10.1101/gad.55671.

[23] S. Decle-Carrasco, A. L. Rodríguez-Piña, L. C. Rodríguez-Zapata, and E. Castano, “Current Research on Viral Proteins That Interact With Fibrillarin,” Molecular Biology Reports 50, no. 5 (2023): 4631-4643, https://doi.org/10.1007/s11033-023-08343-2.

[24] Y. Kakihara, T. Makhnevych, L. Zhao, W. Tang, and W. A. Houry, “Nutritional Status Modulates Box C/D snoRNP Biogenesis by Regulated Subcellular Relocalization of the R2TP Complex,” Genome Biology 15, no. 7 (2014): 404, https://doi.org/10.1186/PREACCEPT-9527372911278142.

[25] M. Okuwaki, S. Saito, H. Hirawake-Mogi, and K. Nagata, “The Interaction Between Nucleophosmin/NPM1 and the Large Ribosomal Subunit Precursors Contribute to Maintaining the Nucleolar Structure,” Biochimica et Biophysica Acta—Molecular Cell Research 1868, no. 1 (2021): 118879, https://doi.org/10.1016/j.bbamcr.2020.118879.

[26] F. Frottin, F. Schueder, S. Tiwary, et al., “The Nucleolus Functions as a Phase-Separated Protein Quality Control Compartment,” Science 365, no. 6451 (2019): 342-347, https://doi.org/10.1126/science.aaw9157.

[27] V. Tiku, C. Jain, Y. Raz, et al., “Small Nucleoli Are a Cellular Hallmark of Longevity,” Nature Communications 8 (2017): 16083, https://doi.org/10.1038/ncomms16083.

[28] C. J. Bryant, M. A. McCool, L. Abriola, Y. V. Surovtseva, and S. J. Baserga, “A High-Throughput Assay for Directly Monitoring Nucleolar rRNA Biogenesis,” Open Biology 12, no. 1 (2022): 210305, https://doi.org/10.1098/rsob.210305.

[29] Q. Hao and K. V. Prasanth, “Regulatory Roles of Nucleolus Organizer Region-Derived Long Non-Coding RNAs,” Mammalian Genome 33, no. 2 (2022): 402-411, https://doi.org/10.1007/s00335-021-09906-z.

[30] J. Sochorová, F. Gálvez, R. Matyášek, S. Garcia, and A. Kovařík, “Analyses of the Updated ‘Animal rDNA Loci Database’ With an Emphasis on Its New Features,” International Journal of Molecular Sciences 22, no. 21 (2021): 11403, https://doi.org/10.3390/ijms222111403.

[31] G. Poortinga, K. M. Hannan, H. Snelling, et al., “MAD1 and c-MYC Regulate UBF and rDNA Transcription During Granulocyte Differentiation,” EMBO Journal 23, no. 16 (2004): 3325-3335, https://doi.org/10.1038/sj.emboj.7600335.

[32] H. Eagle and E. M. Levine, “Growth Regulatory Effects of Cellular Interaction,” Nature 213, no. 5081 (1967): 1102-1106.

[33] M. J. Miller, “Sensitivity of RNA Synthesis to Actinomycin D Inhibition Is Dependent on the Frequency of Transcription: A Mathematical Model,” Journal of Theoretical Biology 129, no. 3 (1987): 289-299.

[34] R. Q. Jacobs, A. K. Huffines, M. Laiho, and D. A. Schneider, “The Small-Molecule BMH-21 Directly Inhibits Transcription Elongation and DNA Occupancy of RNA Polymerase I In Vivo and In Vitro,” Journal of Biological Chemistry 298, no. 1 (2022): 101450, https://doi.org/10.1016/j.jbc.2021.101450.

[35] D. Drygin, A. Lin, J. Bliesath, et al., “Targeting RNA Polymerase I With an Oral Small Molecule CX-5461 Inhibits Ribosomal RNA Synthesis and Solid Tumor Growth,” Cancer Research 71, no. 4 (2011): 1418-1430, https://doi.org/10.1158/0008-5472.CAN-10-1728.

[36] M. Bossaert, A. Pipier, J. F. Riou, et al., “Transcription-Associated Topoisomerase 2α (TOP2A) Activity Is a Major Effector of Cytotoxicity Induced by G-Quadruplex Ligands,” eLife 10 (2021): e65184.

[37] P. M. Bruno, M. Lu, K. A. Dennis, et al., “The Primary Mechanism of Cytotoxicity of the Chemotherapeutic Agent CX-5461 Is Topoisomerase II Poisoning,” Proceedings of the National Academy of Sciences of the United States of America 117, no. 8 (2020): 4053-4060, https://doi.org/10.1073/pnas.1921649117.

[38] E. Fussner, U. Djuric, M. Strauss, et al., “Constitutive Heterochromatin Reorganization During Somatic Cell Reprogramming,” EMBO Journal 30, no. 9 (2011): 1778-1789, https://doi.org/10.1038/emboj.2011.96.

[39] C. Bersaglieri, J. Kresoja-Rakic, S. Gupta, et al., “Genome-Wide Maps of Nucleolus Interactions Reveal Distinct Layers of Repressive Chromatin Domains,” Nature Communications 13, no. 1 (2022): 1483, https://doi.org/10.1038/s41467-022-29146-2.

[40] M. Chebrout, M. C. Koné, H. U. Jan, et al., “Transcription of rRNA in Early Mouse Embryos Promotes Chromatin Reorganization and Expression of Major Satellite Repeats,” Journal of Cell Science 135, no. 6 (2022): jcs258798, https://doi.org/10.1242/jcs.258798.

[41] K. L. Dunn, H. Zhao, and J. R. Davie, “The Insulator Binding Protein CTCF Associates With the Nuclear Matrix,” Experimental Cell Research 288, no. 1 (2003): 218-223.

[42] Y. H. Huang, K. Cai, P. P. Xu, et al., “CREBBP/EP300 Mutations Promoted Tumor Progression in Diffuse Large B-Cell Lymphoma Through Altering Tumor-Associated Macrophage Polarization via FBXW7-NOTCH-CCL2/CSF1 Axis,” Signal Transduction and Targeted Therapy 6, no. 1 (2021): 10, https://doi.org/10.1038/s41392-020-00437-8.

[43] G. Penalosa-Ruiz, V. Bousgouni, J. P. Gerlach, et al., “WDR5, BRCA1, and BARD1 Co-Regulate the DNA Damage Response and Modulate the Mesenchymal-To-Epithelial Transition During Early Reprogramming,” Stem Cell Reports 12, no. 4 (2019): 743-756.

[44] J. H. Seo, S. W. Jang, Y.-J. Jeon, et al., “Acceleration of Mesenchymal-To-Epithelial Transition (MET) During Direct Reprogramming Using Natural Compounds,” Journal of Microbiology and Biotechnology 32, no. 10 (2022): 1245-1252, https://doi.org/10.4014/jmb.2208.08042.

[45] H. Kagawa, R. Shimamoto, S.-I. Kim, et al., “OVOL1 Influences the Determination and Expansion of iPSC Reprogramming Intermediates,” Stem Cell Reports 12, no. 2 (2019): 319-332, https://doi.org/10.1016/j.stemcr.2018.12.008.

[46] P. Samavarchi-Tehrani, A. Golipour, L. David, et al., “Functional Genomics Reveals a BMP-Driven Mesenchymal-To-Epithelial Transition in the Initiation of Somatic Cell Reprogramming,” Cell Stem Cell 7, no. 1 (2010): 64-77, https://doi.org/10.1016/j.stem.2010.04.015.

[47] K. Hu, “Quick,Coordinated and Authentic Reprogramming of Ribosome Biogenesis During iPSC Reprogramming,” Cells 9, no. 11 (2020): 2484, https://doi.org/10.3390/cells9112484.

[48] N. Savic, D. Bär, S. Leone, et al., “lncRNA Maturation to Initiate Heterochromatin Formation in the Nucleolus Is Required for Exit From Pluripotency in ESCs,” Cell Stem Cell 15, no. 6 (2014): 720-734.

[49] N. A. Tchurikov and Y. V. Kravatsky, “The Role of rDNA Clusters in Global Epigenetic Gene Regulation,” Frontiers in Genetics 12 (2021): 730633.

[50] A. Vertii, J. Ou, J. Yu, et al., “Two Contrasting Classes of Nucleolus-Associated Domains in Mouse Fibroblast Heterochromatin,” Genome Research 29, no. 8 (2019): 1235-1249, https://doi.org/10.1101/gr.247072.118.

[51] L. Xiong, E. A. Tolen, J. Choi, et al., “Oct4 Differentially Regulates Chromatin Opening and Enhancer Transcription in Pluripotent Stem Cells,” eLife 11 (2022): e71533, https://doi.org/10.7554/eLife.71533.

[52] E. I. Bakhmet and A. N. Tomilin, “Key Features of the POU Transcription Factor Oct4 From an Evolutionary Perspective,” Cellular and Molecular Life Sciences 78, no. 23 (2021): 7339-7353, https://doi.org/10.1007/s00018-021-03975-8.

[53] D. Han, G. Wu, R. Chen, et al., “A Balanced Oct4 Interactome Is Crucial for Maintaining Pluripotency,” Science Advances 8, no. 7 (2022): eabe4375, https://doi.org/10.1126/sciadv.abe4375.

[54] S. Li, F. Xiao, J. Zhang, et al., “Disruption of OCT4 Ubiquitination Increases OCT4 Protein Stability and ASH2L-B-Mediated H3K4 Methylation Promoting Pluripotency Acquisition,” Stem Cell Reports 11, no. 4 (2018): 973-987, https://doi.org/10.1016/j.stemcr.2018.09.001.

[55] M. Percharde, C. J. Lin, Y. Yin, et al., “A LINE1-Nucleolin Partnership Regulates Early Development and ESC Identity,” Cell 174, no. 2 (2018): 391-405.e19.

[56] N. Hamdane, M. G. Tremblay, S. Dillinger, V. Y. Stefanovsky, A. Németh, and T. Moss, “Disruption of the UBF Gene Induces Aberrant Somatic Nucleolar Bodies and Disrupts Embryo Nucleolar Precursor Bodies,” Gene 612 (2017): 5-11, https://doi.org/10.1016/j.gene.2016.09.013.

[57] K. Hu, W. Li, S. Ma, D. Fang, and J. Xu, “The Identification and Classification of Candidate Genes During the Zygotic Genome Activation in the Mammals,” Zygote 32 (2024): 1-11.

[58] S. Q. Xie, B. J. Leeke, C. Whilding, et al., “Nucleolar-Based dux Repression Is Essential for Embryonic Two-Cell Stage Exit,” Genes & Development 36, no. 5-6 (2022): 331-347, https://doi.org/10.1101/gad.349172.121.

[59] I. Boussaid and M. Fontenay, “Translation Defects in Ribosomopathies,” Current Opinion in Hematology 29, no. 3 (2022): 119-125.

[60] L. Yang, X. Liu, L. Song, et al., “Transient dux Expression Facilitates Nuclear Transfer and Induced Pluripotent Stem Cell Reprogramming,” EMBO Reports 21, no. 9 (2020): e50054, https://doi.org/10.15252/embr.202050054.

[61] G. Scesa, R. Adami, and D. Bottai, “iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter?,” Cells 10, no. 6 (2021): 1470, https://doi.org/10.3390/cells10061470.

[62] G. Yu, L. G. Wang, Y. Han, and Q. Y. He, “clusterProfiler: An R Package for Comparing Biological Themes Among Gene Clusters,” OMICS 16, no. 5 (2012): 284-287, https://doi.org/10.1089/omi.2011.0118.

[63] G. Yu, L. G. Wang, and Q. Y. He, “ChIPseeker: An R/Bioconductor Package for ChIP Peak Annotation, Comparison and Visualization,” Bioinformatics 31, no. 14 (2015): 2382-2383.

[64] P. Bardou, J. Mariette, F. Escudié, C. Djemiel, and C. Klopp, “Jvenn: An Interactive Venn Diagram Viewer,” BMC Bioinformatics 15, no. 1 (2014): 293, https://doi.org/10.1186/1471-2105-15-293.

RIGHTS & PERMISSIONS

2025 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.